Member Info for violindog

Miavoce - agree ..but i find it unbelievable that the SCOPE results have not triggered a partnership well before now. Yes, im sure that there are potential discussions in the background but its increadable that a major hasnt secured the "gold standard" of treatment SCOPE provides and get a step ahead of the opposition. You would think that they wouldnt quibble over what Scancell asks if they look at future revenue streams - especially if SCOPE can become a pre emptive vaccine given to all . Trinity say 37 p - surely £1 would secure the SCIB platform leaving Modi and GT for Scancell to develop .

EE - i have said the same as PH in his interview ...the only difference is i pointed out if Scancell goes it alone- then its dilutive funding : ((

If only we were listed in the USA !!

It’s very clear now from the SP reaction to today’s news that the science has delivered but the share price is TOTALLY dependent upon finance. I thought the interview was a little depressing…. my interpretation was that there are interested parties - but despite the amazing results no one has got the cheque book out - so Scancell are prepared to go it alone which will mean fundraising and further dilution if you don’t participate.

Hence why we are down today despite the excellent results.

Some good volume as well 🤞

We certainly deserve….something !!

Feel slightly more optimistic and from the Chief Moaner that’s a major improvement 🤣

Just wondering how much value Sea Lion is currently contributing to Nav’s share price..

🤡

Unless it’s an intra day RNS…it looks like Sharkeys is closed today 🤣

For new investors…just look at Navitas ‘s share graph for the last 5 years ! Exceptional growth even taking into account what has happened during this time period…covid..general market slump / recovery, oil price fluctuations, Israel fighting both on the ground and global opinion, the list could go on. The underlying message is oil extraction has made Navitas investors very wealthy especially those who got in early and held despite the above . Yes there are risks ahead , none of us know what the future holds but that graph set against the last 5yrs of geopolitical events and the oil price fluctuations should give extreme confidence the future post FID is exceptional 🤞

Mirasol, agree with you, it would be naive to think that there won’t be any involvement between the FIG and HMG especially as Argentina will no doubt complain to the UN etc. However Starmer would be unable to do anything but support the FIG , he’s in enough political trouble…thankfully. Perhaps FID will be announced on budget day 🤣🤣

Starmer and this crippled government doesn’t need any more hassle…they won’t and can’t interfere .

B99, hopefully the drilling results will encourage GGP to make a bid and even if they have their hands full with their current development they can “land bank” the asset .

Unfortunately not today..low volume and a HUGE spread 🙁

B99, if news was that imminent the SP would be higher and not struggling to hold the 50’s

Berm , re your last post …. And there lies one of the reasons we are at 10 p and can’t gain traction despite excellent clinical results. SCLP management have added another unknown aspect in relation to GT instead of focusing on Scib and Moditope. The questions around funding and the company structure is a millstone around the SP until it’s made clear .

West Dome Deeps….. just reminds me of the Lord of the Rings, and the Hobbit with the dragon guarding the huge gold pile 🤣🤣🤣

Looks like nothing is going to happen until we get a deal . Unbelievable that there isn’t any movement upwards after the latest news and conference. We need that milestone payment ASAP otherwise we will be trying to negotiate any potential deal with a distressed cash balance or fundraising at these levels.

From today’s RNS it’s clear that iSCIB1+ is a clinical success with the potential of a “Blockbuster “ status if it was in the arms of a major pharmaceutical company.

However , the SP reaction this morning , and Scancells continued miserable SP , reflects the fact that there’s still a long road ahead towards commercial success and Scancell need a partner with deep pockets. Until we get this partnership deal the SP will remain where it is . The next potential payment from Genmab won’t cover the development cost going forward . Redmile and Vulps are still supporting the current management but they really need to deliver a deal ASAP as the clinical data is in its final stage and the SP is stuck until we finally receive a clear path going forward.

The only issue with a four month runway is that you can’t leave a cash raise to the last minute.. these things take time especially with Xmas and the NY period so we need a revenue stream ASAP to avoid a fundraising.

🥱

The best time for a simultaneous announcement in the UK, Israel, and the Falklands would be 9:00 AM UK time (GMT/BST), as this is 11:00 AM in Israel and 6:00 AM in the Falklands. This makes the announcement happen during the standard workday in Israel, the morning for people in the UK, and before the typical start of the business day in the Falklands, making it the most reasonable balance.